SCHEMBL2994631

SCHEMBL2994631

Oc1ccc(-c2ccnc(-c3cccc(-c4ccccc4)n3)c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.58
POLB P06746 1/20 0.58
MAPT P10636 1/20 0.58
HPGD P15428 1/20 0.58
HSD17B10 Q99714 1/20 0.58
RAB9A P51151 2/20 0.51
NPC1 O15118 1/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
NTSR1 P30989 1/20 0.50
CDK5 Q00535 2/20 0.48
CDK5R1 Q15078 2/20 0.48
ESR1 P03372 4/20 0.47
MMP3 P08254 1/20 0.46
BCL2L1 Q07817 1/20 0.46
ESR2 Q92731 3/20 0.45
HSD17B1 P14061 2/20 0.44
HSD17B2 P37059 2/20 0.44
MKNK1 Q9BUB5 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2989004 0.85 CTRC (0.50) ALDH1A1RAB9AMEN1KMT2ASMO
SCHEMBL23598407 0.83 MEN1 (0.53) ALDH1A1MAPTHPGDRAB9AMEN1
SCHEMBL1991845 0.82 KDM4E (0.64) ALDH1A1POLBMAPTHPGDHSD17B10
SCHEMBL28593175 0.80 POLB (0.70) ALDH1A1POLBMAPTHPGDHSD17B10
SCHEMBL15024091 0.80 KDM4E (0.67) ALDH1A1POLBMAPTHPGDHSD17B10
SCHEMBL3194223 0.78 CYP19A1 (0.53) RAB9AMEN1KMT2ASMO
SCHEMBL20220123 0.78 MEN1 (0.71) ALDH1A1POLBMAPTHPGDHSD17B10
SCHEMBL22538001 0.78 MEN1 (0.71) ALDH1A1POLBMAPTHPGDHSD17B10
SCHEMBL30901160 0.78 MEN1 (0.71) ALDH1A1POLBMAPTHPGDHSD17B10
SCHEMBL17694751 0.78 ASIC3 (0.61) RAB9ANPC1MEN1KMT2AMKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8357800-B2 Bipyridine metal complexes for use as light-emitting material SOLVAY (SOCIETE ANONYME) (BE) 2013-01-22 US disclosed
US-20100174078-A1 Bipyridine metal complexes for use as light-emitting material SOLVAY (SOCIETE ANONYME) (BE) 2010-07-08 US disclosed
EP-2155765-A1 BIPYRIDINE METAL COMPLEXES FOR USE AS LIGHT-EMITTING MATERIAL SOLVAY (BE) 2010-02-24 EP disclosed
WO-2008148830-A1 BIPYRIDINE METAL COMPLEXES FOR USE AS LIGHT-EMITTING MATERIAL SOLVAY (BE) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100174078-A1 Bipyridine metal complexes for use as light-emitting material OCIAD2, AP2M1, OCIAD1 ALDH1A1 2456/4885POLB 3242/4885MAPT 164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.